TRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease
Pediatric Practice and Research · 29.06.2026 · 14 (1) · 11833482
DOI: 10.21765/pprjournal.1833482 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Practice and Research, online erschienen am 29.06.2026. Verfasst von Aslı Kantar und 9 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben. Gefördert von: Department of Pediatric Nephrology, University of Health Sciences, Dr. Behçet Uz Children’s Hospital, İzmir, Turkey.
Abstract (Originalsprache)
Background
TRACK syndrome, first described by Canpolat et al., is a rare disorder caused by splice-site mutations in TSEN2, characterized by craniofacial malformations, central nervous system (CNS) anomalies, progressive kidney disease. Case Presentation: We present a 2.5-year-old boy, third child of consanguineous parents, admitted with fever and cough, diagnosed with atypical hemolytic uremic syndrome (aHUS). Whole exome sequencing revealed a homozygous intronic TSEN2 variant (c.1100-5T>A), consistent with TRACK syndrome. Two deceased siblings had similar dysmorphic features and early-onset renal failure. The proband exhibited microcephaly, craniofacial dysmorphism, left atrial dilation, and laboratory findings consistent with thrombotic microangiopathy (TMA). Despite pathogenic TSEN2 variant, he’d normal intellectual and motor development. He’s currently 6 years old, undergoing peritoneal dialysis, receiving biweekly eculizumab, and antiepileptic therapy.
Conclusion
This report highlights a rare cause of aHUS and end-stage kidney disease (ESKD) due to a TSEN2 splice-site mutation, further expanding the phenotypic spectrum of TRACK syndrome.
Förderung
- Department of Pediatric Nephrology, University of Health Sciences, Dr. Behçet Uz Children’s Hospital, İzmir, Turkey
Zitieren
APA
Kantar, A., Güllü, D., Yaman, Y., Zorlu, B. P., Özmen, D., Devrim, F., Gözmen, Ş. K., Hazan, F., Ünalp, A., & Dinçel, N. (2026). TRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease. Pediatric Practice and Research, 14(1), 11833482. https://doi.org/10.21765/pprjournal.1833482
Vancouver
Kantar A, Güllü D, Yaman Y, Zorlu BP, Özmen D, Devrim F, et al. TRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease. Pediatric Practice and Research. 2026;14(1):11833482. doi:10.21765/pprjournal.1833482
BibTeX
@article{Kantar2026,
author = {Kantar, Aslı and Güllü, Duygu and Yaman, Yakup and Zorlu, Betül Pehlivan and Özmen, Derya and Devrim, Fatma and Gözmen, Şükran Keskin and Hazan, Filiz and Ünalp, Aycan and Dinçel, Nida},
title = {TRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease},
journal = {Pediatric Practice and Research},
year = {2026},
volume = {14},
number = {1},
pages = {11833482},
doi = {10.21765/pprjournal.1833482}
}
EUVIMED